In KRAS-mutated NSCLC cells, the addition of transforming growth factor-β1 (TGF-β1) decreased DNMT1 activity, with resulting PD-L1 promoter hypo-methylation. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.